SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-09-057796
Filing Date
2009-12-18
Accepted
2009-12-18 16:57:10
Documents
1
Period of Report
2009-12-09

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING rrd260449.html 3  
1 INITIAL FILING rrd260449.xml 3 3251
  Complete submission text file 0001181431-09-057796.txt   6031
Mailing Address 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025
Business Address 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025 310-883-1300
Abraxis BioScience, Inc. (Reporting) CIK: 0001409012 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-52974 | Film No.: 091250659
SIC: 2834 Pharmaceutical Preparations

Mailing Address 317 MADISON AVE. SUITE 1520 NEW YORK NY 10017
Business Address 317 MADISON AVE. SUITE 1520 NEW YORK NY 10017 (212) 953-1544
Stalar 4, Inc. (Issuer) CIK: 0001419982 (see all company filings)

IRS No.: 261402673 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025
Business Address 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025 310-883-1300
Abraxis BioScience, LLC (Reporting) CIK: 0001450648 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-52974 | Film No.: 091250658